| Dr Renata Burigatto, MD | |
|
701 E Marshall St, West Chester, PA 19380 | |
| (610) 431-5000 | |
| Not Available |
| Full Name | Dr Renata Burigatto |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 701 E Marshall St, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760503239 | NPI | - | NPPES |
| 1023728030001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD436169 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Medicine Home Health | Bala cynwyd, PA | Home health agency |
| Chester County Hospital | West chester, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Care Associates Of The University Of Pennsylvania Health | 4688588866 | 517 |
News Archive
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
A new study suggests that states may not save as much money as anticipated by eliminating adult dental coverage under Medicaid.
It's a metabolite found in essentially all our cells that, like so many things, cancer overexpresses. Now scientists have shown that when they inhibit 20-HETE, it reduces both the size of a breast cancer tumor and its ability to spread to the lungs.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the fourth quarter of 2009 increased 12 percent to a quarterly record of $28.6 million compared to $25.5 million for the fourth quarter of 2008. This was the 12th consecutive quarter of profitability for the Company.
TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells in the upper airways. The bacteria call up more permissive white blood cells in the deeper regions of the lungs and hitch a ride inside them to get into the host's body.
› Verified 4 days ago
| Entity Name | Clinical Care Associates Of The University Of Pennsylvania Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972682995 PECOS PAC ID: 4688588866 Enrollment ID: O20031113000301 |
News Archive
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
A new study suggests that states may not save as much money as anticipated by eliminating adult dental coverage under Medicaid.
It's a metabolite found in essentially all our cells that, like so many things, cancer overexpresses. Now scientists have shown that when they inhibit 20-HETE, it reduces both the size of a breast cancer tumor and its ability to spread to the lungs.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the fourth quarter of 2009 increased 12 percent to a quarterly record of $28.6 million compared to $25.5 million for the fourth quarter of 2008. This was the 12th consecutive quarter of profitability for the Company.
TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells in the upper airways. The bacteria call up more permissive white blood cells in the deeper regions of the lungs and hitch a ride inside them to get into the host's body.
› Verified 4 days ago
| Entity Name | Jefferson University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326093675 PECOS PAC ID: 7911819180 Enrollment ID: O20040225000232 |
News Archive
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
A new study suggests that states may not save as much money as anticipated by eliminating adult dental coverage under Medicaid.
It's a metabolite found in essentially all our cells that, like so many things, cancer overexpresses. Now scientists have shown that when they inhibit 20-HETE, it reduces both the size of a breast cancer tumor and its ability to spread to the lungs.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the fourth quarter of 2009 increased 12 percent to a quarterly record of $28.6 million compared to $25.5 million for the fourth quarter of 2008. This was the 12th consecutive quarter of profitability for the Company.
TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells in the upper airways. The bacteria call up more permissive white blood cells in the deeper regions of the lungs and hitch a ride inside them to get into the host's body.
› Verified 4 days ago
| Entity Name | Methodist Associates In Healthcare, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053355131 PECOS PAC ID: 6406755651 Enrollment ID: O20040402000835 |
News Archive
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
A new study suggests that states may not save as much money as anticipated by eliminating adult dental coverage under Medicaid.
It's a metabolite found in essentially all our cells that, like so many things, cancer overexpresses. Now scientists have shown that when they inhibit 20-HETE, it reduces both the size of a breast cancer tumor and its ability to spread to the lungs.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the fourth quarter of 2009 increased 12 percent to a quarterly record of $28.6 million compared to $25.5 million for the fourth quarter of 2008. This was the 12th consecutive quarter of profitability for the Company.
TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells in the upper airways. The bacteria call up more permissive white blood cells in the deeper regions of the lungs and hitch a ride inside them to get into the host's body.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Renata Burigatto, MD 701 E Marshall St, West Chester, PA 19380-4412 Ph: (610) 431-5000 | Dr Renata Burigatto, MD 701 E Marshall St, West Chester, PA 19380 Ph: (610) 431-5000 |
News Archive
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
A new study suggests that states may not save as much money as anticipated by eliminating adult dental coverage under Medicaid.
It's a metabolite found in essentially all our cells that, like so many things, cancer overexpresses. Now scientists have shown that when they inhibit 20-HETE, it reduces both the size of a breast cancer tumor and its ability to spread to the lungs.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the fourth quarter of 2009 increased 12 percent to a quarterly record of $28.6 million compared to $25.5 million for the fourth quarter of 2008. This was the 12th consecutive quarter of profitability for the Company.
TB-causing bacteria appear to mask their identity to avoid recognition by infection-killing cells in the upper airways. The bacteria call up more permissive white blood cells in the deeper regions of the lungs and hitch a ride inside them to get into the host's body.
› Verified 4 days ago
Kevin Sowti, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5000 | |
Dr. Richard O Oyelewu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 E. Marshall St, West Chester, PA 19380 Phone: 610-431-5262 Fax: 484-337-4082 | |
Swapna Gummadi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5000 |